Literature DB >> 12401299

Strategies to prevent CMV infection in the neonate.

Paul D Griffiths1.   

Abstract

Congenital cytomegalovirus (CMV) infection is a major cause of sensorineural hearing loss and mental retardation, whose annual healthcare costs in the USA approximate to one billion dollars. Only a minority of neonates with this infection has symptoms present at birth and some of the damage to ear and brain occurs in the first few months of life. Extensive studies of CMV infection have been conducted in pregnant women and their children to define the natural history of this infection. What is required now is a concerted commitment to tackle this clinical problem using one or more of the following strategies: avoid iatrogenic transmission; advise those at risk how to avoid acquisition; provide diagnosis in an individual neonate or pregnant woman and offer treatment; develop and deploy a CMV vaccine. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401299     DOI: 10.1016/s1084-2756(02)90123-5

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  13 in total

1.  Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.

Authors:  Fernando J Bravo; David I Bernstein; James R Beadle; Karl Y Hostetler; Rhonda D Cardin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.

Authors:  Takako Tabata; Matthew Petitt; Martin Zydek; June Fang-Hoover; Nicholas Larocque; Mitsuru Tsuge; Matthew Gormley; Lawrence M Kauvar; Lenore Pereira
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection.

Authors:  Ranjit I Kylat; Edmond N Kelly; Elizabeth Lee Ford-Jones
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

4.  Diagnosis of and screening for cytomegalovirus infection in pregnant women.

Authors:  S C Munro; B Hall; L R Whybin; L Leader; P Robertson; G T Maine; W D Rawlinson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.

Authors:  Kristina Abel; Joy Martinez; Yujuan Yue; Simon F Lacey; Zhongde Wang; Lisa Strelow; Anindya Dasgupta; Zhongqi Li; Kimberli A Schmidt; Kristie L Oxford; Basel Assaf; Jeffrey A Longmate; Don J Diamond; Peter A Barry
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

6.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

7.  Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.

Authors:  Kristie L Oxford; Lisa Strelow; Yujuan Yue; W L William Chang; Kimberli A Schmidt; Don J Diamond; Peter A Barry
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

8.  Rehabilitation and outcome of severe profound deafness in a group of 16 infants affected by congenital cytomegalovirus infection.

Authors:  Andrea Ciorba; Roberto Bovo; Patrizia Trevisi; Chiara Bianchini; Rosa Arboretti; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

9.  Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission.

Authors:  Mark R Schleiss; Michael A McVoy
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

Review 10.  Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on.

Authors:  J Hassan; J Connell
Journal:  Clin Exp Immunol       Date:  2007-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.